Phibro Animal Health | PAHC - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Align Technology USD 4.23B 83.03M 2026-06
ANI Pharmaceuticals USD 597.21M 34.91M 2026-06
Aurora Cannabis CAD 511.83M 24.53M 2026-03
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Canopy Growth CAD 697.59M 60.58M 2026-03
Corcept Therapeutics USD 705.78M 67.79M 2026-06
Eli Lilly USD 33.88B 2.68B 2026-06
Henry Schein USD 3.16B 109M 2026-06
Idexx Laboratories USD 1.61B 56.47M 2026-06
Knight Therapeutics CAD 767.27M 480K 2025-12
Merck USD 41.93B 3.94B 2026-06
Nektar Therapeutics USD 576.22M 486.38M 2026-03
Pacira USD 671.98M 18.08M 2026-06
Phibro Animal Health USD 385.48M 23.65M 2026-06
Prestige Brands USD 1.92B 29.2M 2026-06
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
Zoetis USD 3.15B 85M 2026-06